ADDITIONS TO PERKINELMER LABWORKS SOFTWARE SIMPLIFY SCHEDULING, QUERYING AND REPORTING FOR LIMS USERS

 

 

BOSTON — PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions, today announced a range of new capabilities for its LABWORKSTM ES laboratory information management system (LIMS) software that significantly improve scheduling, organizing and reporting critical laboratory data.

 

Among the new capabilities is a Process Scheduler module used to schedule routine sampling and to monitor sample statuses throughout an organization. The Process Scheduler can flexibly define sampling groups based on time, frequency, sample locations, and type of analysis. The new Calendar View also allows viewing of timed samples in a monthly or daily format and the color-coded system makes determining sample statuses easier.

 

Other additions include a sophisticated new query function that makes it easy for users to work with data in both LABWORKS and outside databases. The new query function operates through an intuitive, graphical interface that is easy to navigate and does not require specialized database management expertise. Users only see the information relevant to their specific needs and managers can limit information based on user authorization.

 

“The new capabilities added to LABWORKS help to automate some of the most important ongoing tasks in any lab,” said Stephen Delity, analytical solutions business manager for PerkinElmer Life and Analytical Sciences. “Saving time with sample-oriented work flow, more powerful analysis and reporting are top priorities for lab managers who need to maximize productivity and deliver secure, reliable results for better decision making. This LABWORKS update will meet the growing needs of users and managers in a wide variety of labs.”

 

For alternative security procedures required in various labs, the LABWORKS logon can now be set-up for three authentication options. New LABWORKS ES LIMS automated reporting allows reports from samples logged into LABWORKS to be transmitted to the sample submitter’s email address as PDF files. Users can also request reports via the Intranet or Internet using the Crystal Enterprise software tool.

 

For more information about LABWORKS ES LIMS software from PerkinElmer, contact PerkinElmer at 1-800-762-4060 or visit www.perkinelmer.com.

 

Factors Affecting Future Performance

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as “believes,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to cyclical downturns affecting several of the industries into which we sell our products, our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, risks related to our international operations, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that  may require us to stop selling products or lose competitive advantage, competition, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption “Forward-Looking Information and Factors Affecting Future Performance” in our most recently filed annual report on Form 10-K and in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

 

PerkinElmer, Inc. is a global technology leader focused in the following businesses – Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers’ needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability.   The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index.  Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

 

 

# # #

           

For further information:            

Investor Contact:                                  Media Contact:

Dan Sutherby                                       Paul Mormack

PerkinElmer, Inc.                                  Brodeur Worldwide

(781) 431-4306                                    (518) 434-1819

 

 

 

LABWORKS is a trademark of PerkinElmer, Inc.